Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Conditions

• Cervical Intraepithelial Neoplasia
• Cervical Cancer
• Persistent Infection

Interventions

• BIOLOGICAL: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli)
• OTHER: No intervention
• BIOLOGICAL: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli)

Sponsor

Xiamen University

Collaborators

• [object Object]
• [object Object]